eCase Challenge 2: Moving Forward: Implementation of Strategies that Improve Outcomes in Patients with Irritable Bowel Syndrome
This self-assessment activity outlines current guidelines, management and treatment that improve outcomes in patients with IBS. Also available, eCase Challenge 1: Moving Forward: Implementation of Strategies that Improve Outcomes in Patients with Irritable Bowel Syndrome.

eCase Challenge 2: Moving Forward: Implementation of Strategies that Improve Outcomes in Patients with Irritable Bowel Syndrome

Richard H. Davis Jr, PA-C

Although IBS is a relatively common gastrointestinal disorder, only about one-third of patients will seek medical care for their symptoms. As most patients will present in the primary care setting, it is critical that PAs remain up to date on current diagnostic guidelines and how best to make diagnoses based on symptom presentation and exclusion of other underlying causes. Clinicians should be aware of common etiologies associated with IBS given that therapies for symptom management target the potential underlying pathological mechanisms. Clinicians should also review currently approved medications for IBS symptom relief and be especially cognizant of which medications are indicated for each IBS subtype.

Educational Objectives

At the conclusion of this activity, the PA should be better able to:

  • Describe the current diagnostic criteria for IBS based on the Rome IV guidelines and be better able to stratify patients based on their IBS subtype.
  • Discuss potential IBS etiologies, including altered intestinal motility, visceral hypersensitivity and disturbances in the gut microbiota, and how they may provide a basis for the pharmacological development of therapies.
  • Summarize the pharmacological therapies with approved labeling for IBS and review their mechanisms of action, stressing the importance of matching the appropriate therapy with the specific IBS subtype.

Accreditation Statement

This activity has been reviewed and is approved for a maximum of 0.50 AAPA Category 1 Self-Assessment CME credit by the AAPA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. Approval is valid until January 31, 2018.

Responsibility Statement

AAPA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Faculty

Richard H. Davis Jr, PA-C
Senior PA
Division of Gastroenterology, Hepatology and Nutrition
University of Florida College of Medicine
Gainesville, FL
No relationship with any commercial interests whose products or services may be mentioned during this presentation.

Activity Planners

Michael Speidel and Joanne Jeffers, Medical Logix, LLC and Judy Crespi-Lofton, MS have no relationship with any commercial interests whose products or services may be mentioned during this presentation.

AAPA Staff Activity Planners

Daniel Pace and Jennifer Williams have no relationship with any commercial interests whose products or services may be mentioned during this presentation.

Off-Label/Unapproved Product(s) Discussion

Richard H. Davis Jr, PA-C: Tricyclic antidepressants, SSRI antidepressants, Bile acid sequestrants.

Disclaimer

The opinions and comments expressed by faculty and other experts, whose input is included in this program, are their own. This enduring material is produced for educational purposes only. Please review complete prescribing information of specific drugs mentioned in this program including indications, contraindications, warnings, and adverse effects and dosage before administering to patients.

Acknowledgement of Commercial Support

Jointly supported by an independent educational grant from Allergan and Ironwood Pharmaceuticals.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.


Type:     Internet Activity (Enduring Material)
195 Registered Users